Vancity Investment Management Ltd Makes New $8.63 Million Investment in CME Group Inc. $CME

Vancity Investment Management Ltd acquired a new position in shares of CME Group Inc. (NASDAQ:CME) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 32,539 shares of the financial services provider’s stock, valued at approximately $8,632,000. CME Group makes up approximately 1.2% of Vancity Investment Management Ltd’s holdings, making the stock its 28th biggest position.

A number of other hedge funds have also modified their holdings of CME. Wayfinding Financial LLC bought a new position in CME Group in the first quarter valued at approximately $25,000. Cornerstone Planning Group LLC lifted its holdings in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 55 shares during the last quarter. Golden State Wealth Management LLC lifted its holdings in CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 98 shares during the last quarter. Alpine Bank Wealth Management acquired a new stake in CME Group during the 1st quarter worth approximately $32,000. Finally, Financial Gravity Asset Management Inc. acquired a new stake in CME Group during the 1st quarter worth approximately $32,000. 87.75% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Wall Street Zen cut CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Citigroup lifted their price target on CME Group from $265.00 to $275.00 and gave the stock a “neutral” rating in a report on Thursday, July 3rd. UBS Group reissued a “neutral” rating and set a $305.00 price target on shares of CME Group in a report on Thursday, July 24th. Erste Group Bank cut CME Group from a “strong-buy” rating to a “hold” rating in a report on Saturday, May 24th. Finally, Oppenheimer lifted their price target on CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a report on Thursday, July 24th. Four analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus target price of $261.93.

CME Group Trading Down 2.1%

Shares of CME stock opened at $261.94 on Monday. The firm has a market capitalization of $94.40 billion, a P/E ratio of 25.36, a P/E/G ratio of 4.74 and a beta of 0.43. CME Group Inc. has a twelve month low of $212.38 and a twelve month high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock’s fifty day simple moving average is $274.96 and its 200 day simple moving average is $270.15.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.56 EPS. As a group, sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group’s dividend payout ratio is 48.40%.

Insiders Place Their Bets

In other CME Group news, Director Charles P. Carey sold 500 shares of the stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the sale, the director owned 4,900 shares in the company, valued at $1,300,215. This represents a 9.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director William R. Shepard acquired 256 shares of the stock in a transaction that occurred on Wednesday, June 25th. The stock was acquired at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the transaction, the director directly owned 258,196 shares of the company’s stock, valued at $69,849,763.88. This represents a 0.10% increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.